The best indicator for CVS Health (CVS)
We backtested 366 indicators across daily, weekly and hourly charts on real CVS Health (CVS) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
DeMarker (14)
On the weekly chart, this is the strongest risk-adjusted edge we found for CVS Health (CVS) over ~53.5 years — beating buy-and-hold by 0.3% CAGR.
Best multi-indicator combo
Going long only when all 2 agree was the strongest confluence setup we found for CVS Health (CVS) — trailing buy-and-hold by 2.3% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | DeMarker (14) ✓ | Weekly | 10.1% | 0.56 | -53.0% | 54.8% | 124 | 0.3% |
| 2 | Aroon ✓ | Weekly | 9.5% | 0.55 | -50.2% | 55.3% | 85 | -0.4% |
| 3 | QQE ✓ | Weekly | 12.0% | 0.55 | -73.5% | 51.8% | 166 | 2.2% |
| 4 | Aroon Oscillator ✓ | Weekly | 9.5% | 0.55 | -50.2% | 55.3% | 85 | -0.4% |
| 5 | Positive Volume Index ✓ | Daily | 9.0% | 0.52 | -46.1% | 35.7% | 126 | -1.0% |
| 6 | Supertrend (10,3) ✓ | Weekly | 8.3% | 0.5 | -45.6% | 45.5% | 33 | -1.5% |
| 7 | DMI Direction ✓ | Weekly | 8.7% | 0.5 | -47.3% | 44.8% | 105 | -1.2% |
| 8 | DeMarker (21) ✓ | Weekly | 8.8% | 0.5 | -53.6% | 54.7% | 86 | -1.1% |
| 9 | McGinley 100 Trend ✓ | Daily | 11.8% | 0.53 | -64.1% | 21.4% | 14 | 1.8% |
| 10 | Guppy Multiple MA ✓ | Weekly | 8.5% | 0.49 | -58.4% | 43.2% | 37 | -1.3% |
| 11 | Cutler's RSI ✓ | Weekly | 8.2% | 0.49 | -51.0% | 55.0% | 151 | -1.7% |
| 12 | RSI (25) ✓ | Weekly | 8.4% | 0.49 | -52.8% | 41.9% | 93 | -1.4% |
| 13 | ROC (14) ✓ | Weekly | 8.2% | 0.49 | -51.0% | 55.0% | 151 | -1.7% |
| 14 | CMO (14) ✓ | Weekly | 8.2% | 0.49 | -51.0% | 55.0% | 151 | -1.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For CVS Health (CVS), DeMarker (14) on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.